(4S)-4-[[(1,1-二甲基乙氧基)羰基]氨基]-1-甲基-D-脯氨酸

D-​Proline, 4-​[[(1,​1-​dimethylethoxy)​carbonyl]​amino]​-​1-​methyl-​, (4S)​-

98%

(3-乙酰基苯氧基)乙酸, ≥99%

(3-Acetylphenoxy)acetic Acid

2,5-二溴-3-己基噻吩, ≥99%,GC

2,5-Dibromo-3-hexylthiophene

三(4,4'-二甲基-2,2'-联吡啶)钌(II)六氟磷酸盐, 99%

Ru(DMB)3(PF6)2

4-(2-氯苯氧基)哌啶盐酸盐, 98%

4-(2-Chlorophenoxy)piperidine hydrochloride

9-(2-溴苯基)咔唑, 98%

9-(2-Bromophenyl)-9H-carbazole

苯基琥珀酸酐, 99.9%

Phenylsuccinic anhydride

2,4-二苯恶唑, ≥99.9%

2,4-Diphenyloxazole

(1S,4S)-2-乙基-2,5-二氮杂双环[2.2.1]庚烷二氢溴化物

(1S,4S)-2-ethyl-2,5-diazabicyclo[2.2.1]heptane dihydrobromide

98%

6-羟基-5-硝基烟腈

6-Hydroxy-5-nitronicotinonitrile

98%

5-Bromo-6-methoxy-2-methylquinoline

0.97

98%

1-异丁基-3-(三氟甲基)-1H-吡唑, 99%

1-Isobutyl-3-(trifluoromethyl)-1H-pyrazole

2-碘-1-三苯甲基-1H-咪唑

2-Iodo-1-trityl-1H-imidazole

96%

(S)-2-氨基-1,1,3-三苯基-1-丙醇, ≥99%,≥99.9% e.e.

(S)-2-Amino-1,1,3-triphenyl-1-propanol

(2S,3S)-(+)-2,3-双(二苯基膦基)双环[2.2.1]庚-5-烯, 98.0%

(2S,3S)-(+)-2,3-Bis(diphenylphosphino)bicyclo[2.2.1]hept-5-ene

2,3,5-三溴吡啶, ≥99%

2,3,5-Tribromopyridine

AMPA受体选择性阻断剂前体, 99% (HPLC)

4-(8-Methyl-9H-[1,3]dioxolo[4',5':4,5]benzo[1,2-d][1,2]diazepin-5-yl)aniline hydrochloride

2-(乙氨基)吡啶, ≥99%

2-(Ethylamino)pyridine

2-氨基-3-硝基-6-氯吡啶, 98%

2-Amino-6-chloro-3-nitropyridine

2-叠氮乙基-2,3,4,6-四-O-乙酰-β-D-吡喃葡萄糖苷, ≥92%

2-Azidoethyl 2,3,4,6-Tetra-O-acetyl-β-D-glucopyranoside